Longevity Peptides9 min read·Published June 3, 2026

Sermorelin: How This GHRH Peptide Works, Uses, and Safety

A patient guide to sermorelin acetate — the GHRH-analog peptide prescribed off-label for sleep, recovery, and healthy aging.

ByDr. Elena Vasquez
Clinically reviewed by Dr. Anika Rao
Sermorelin: How This Growth Hormone Peptide Works

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

Sermorelin is a synthetic 29-amino-acid peptide that copies the active part of growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release more of the body's own growth hormone, which then raises insulin-like growth factor 1 (IGF-1) [1]. Sermorelin's only original FDA approval was for pediatric growth hormone deficiency under the brand Geref, which was later discontinued in the U.S. [2]. All adult uses today — sleep, recovery, body composition, healthy aging — are off-label and accessed primarily through licensed clinicians and 503A compounding pharmacies.

What is sermorelin?

Sermorelin (sermorelin acetate) is a short, lab-made peptide — just 29 amino acids long. It is the active fragment of the body's natural GHRH, the hormone that tells the pituitary gland to release growth hormone [1]. Because it copies the working part of GHRH, it is classified as a GHRH analog.

Sermorelin was first FDA-approved in the 1990s under the brand name Geref for children who could not make enough growth hormone on their own [2]. Geref was later discontinued in the U.S. for commercial reasons — not because of a safety problem. Today, sermorelin is mostly available as a compounded medication prepared by 503A compounding pharmacies under a prescription from a licensed clinician. Sermorelin is one of several longevity peptides — alongside BPC-157, TB-500, CJC-1295/Ipamorelin, GHK-Cu, Epitalon, MOTS-c, NAD+, and Thymosin-alpha-1 — that are currently in the FDA's compounding-review pathway [6].

How does sermorelin work in the body?

The GHRH pathway

Your hypothalamus normally releases GHRH in pulses, mostly at night. GHRH travels a short distance to the pituitary gland, which then releases growth hormone (GH) into the bloodstream. GH signals the liver to make insulin-like growth factor 1 (IGF-1), which carries out many of the downstream effects on muscle, fat, bone, and tissue repair [1][3].

Sermorelin binds to the same receptor as natural GHRH and produces the same downstream signal. The key point: it does not replace growth hormone. It nudges your pituitary to make more of its own.

Why it's different from synthetic HGH

Synthetic or recombinant human growth hormone (somatropin, often called HGH) is the finished hormone itself. Injecting it raises GH in the blood directly, bypassing the body's own controls. Sermorelin works one step earlier in the chain. Because the pituitary still controls how much GH it releases, the body's normal feedback loops stay in place — which may lower the risk of pushing GH and IGF-1 too high [1][3].

What is sermorelin used for?

FDA-approved use

Sermorelin's only original FDA-approved use was for pediatric growth hormone deficiency — children who were not growing at a normal rate because their pituitary did not make enough GH [2]. Since Geref was discontinued, there is no currently marketed FDA-labeled sermorelin product in the U.S.

Common off-label uses in adults

In adults, sermorelin is prescribed off-label. It is currently being studied and used to support people with age-related decline in GH secretion (sometimes called somatopause). Reported areas of interest include sleep quality, exercise recovery, lean body mass, and general well-being [3][4]. These uses are not FDA-approved, and evidence in healthy adults is limited compared with the data in children with GH deficiency.

What benefits do patients report?

Because sermorelin works through the body's natural GH pulse, the reported effects tend to mirror what healthy GH levels support. Evidence quality varies, and individual results vary.

Sleep and recovery

GH is released most heavily during deep (slow-wave) sleep. Some studies suggest that supporting the GHRH pathway can improve slow-wave sleep and next-day recovery [3]. Patients commonly describe falling asleep more easily and waking up feeling more rested, though placebo effects and lifestyle changes are hard to separate out.

Body composition

GH and IGF-1 help shift body composition toward more lean mass and less visceral fat. Studies of GHRH analogs in adults with reduced GH have shown modest reductions in fat mass and improvements in lean mass over months of use [3][4]. Effect sizes are smaller and slower than what people see with direct HGH.

Energy and skin

Patients commonly report better daytime energy, exercise tolerance, and skin quality. These outcomes are harder to measure in trials and rely largely on self-report. Individual results vary, and improvements are gradual — usually appearing over 3–6 months rather than weeks.

How is sermorelin taken?

Subcutaneous injection basics

Sermorelin is given as a small subcutaneous injection — under the skin, usually in the abdomen — with a fine insulin-style needle. It is not available as a pill, because stomach acid would break the peptide down before it could work. Compounded sermorelin is typically dispensed as a reconstituted vial with detailed instructions from the pharmacy and clinician. Patients new to injecting may want to review our peptide injection basics before starting.

Typical timing and cycles

To match the body's natural rhythm, sermorelin is usually given at night on an empty stomach — food (especially carbohydrates and fats) blunts the GH pulse. Typical adult protocols in the literature use daily dosing for several months, sometimes followed by a break, but exact dosing and cycle length must be decided by a clinician based on labs and goals [3]. This article does not provide dosing instructions.

What are the side effects and risks of sermorelin?

Sermorelin is generally well tolerated in published studies, but it is not risk-free. Reported side effects include [2][3]:

  • Injection-site reactions: redness, swelling, mild pain, or itching.
  • Flushing or warmth shortly after injection.
  • Headache or lightheadedness.
  • Nausea or an unusual taste in the mouth.
  • Rarely, allergic reactions — stop the medication and seek care if hives, swelling, or breathing trouble occur.

Because sermorelin raises GH and IGF-1, clinicians screen for conditions that can be worsened by higher GH activity — for example, active cancer, severe respiratory illness, or untreated thyroid disease. Lab monitoring of IGF-1 and other markers is standard. Long-term safety data in healthy adults using sermorelin off-label for anti-aging purposes is limited, which is an important honest caveat.

Sermorelin vs. other growth hormone peptides

Several peptides work on the GH axis. They are not interchangeable. Here is a high-level comparison — your clinician will help match the right tool to your situation. For a deeper look at the category, see our longevity peptides overview.

PeptideClass / MechanismTypical useFDA status (U.S.)
SermorelinGHRH analog — prompts pituitary GH releaseOff-label adult use for sleep, recovery, body compositionApproved only for pediatric GH deficiency (Geref discontinued); adult use off-label; under FDA compounding review, PCAC July 23–24, 2026 [2][6]
IpamorelinGhrelin/GHS-R agonist — separate GH-release pathwayOften stacked with a GHRH analog for amplified GH pulseNot FDA-approved; available compounded; under FDA review [6]
CJC-1295Long-acting GHRH analogLess-frequent dosing; often paired with ipamorelinNot FDA-approved; available compounded; under FDA review [6]
TesamorelinGHRH analogFDA-approved for HIV-associated lipodystrophy [5]FDA-approved (Egrifta) for a specific indication
Somatropin (HGH)Recombinant human growth hormone — direct replacementAdult/pediatric GH deficiency and select conditionsFDA-approved prescription drug

Two common questions: sermorelin vs HGH and sermorelin vs ipamorelin. Sermorelin acts upstream of GH and preserves natural feedback. Ipamorelin works on a separate receptor and is often combined with a GHRH analog to create a stronger, more natural GH pulse — see our ipamorelin and CJC-1295 guide for detail.

Who should not take sermorelin?

Sermorelin is not appropriate for everyone. A licensed clinician will review your history before prescribing. Sermorelin is generally avoided or used with extra caution in people who [2][3]:

  • Have active cancer or a recent history of malignancy.
  • Are pregnant, may become pregnant, or are breastfeeding.
  • Have a known allergy to sermorelin or any component of the formulation.
  • Have untreated thyroid disease, severe obesity with respiratory complications, or other conditions that can affect GH response.
  • Are under 18 (pediatric use is a separate clinical context with specialist oversight).

What peptides stack well with sermorelin?

In compounding-pharmacy practice and the published literature, sermorelin is commonly combined with other longevity peptides that target complementary pathways. These are not Chia-recommended protocols — they are categories a clinician may discuss with you.

  • Sermorelin + Ipamorelin — a GHRH analog (sermorelin) paired with a ghrelin/GHS-R agonist (ipamorelin) hits two separate receptors and can produce a stronger, more pulsatile GH release [3][8]. The safety caveat: combined GH stimulation can amplify side effects like fluid retention or fatigue, and combination-specific trials are limited. See the ipamorelin and CJC-1295 guide.
  • Sermorelin + CJC-1295 — CJC-1295 is a longer-acting GHRH analog; pairing it with sermorelin is sometimes used to provide both a steady baseline and a sharper nightly pulse [3]. The safety caveat: stacking two GHRH analogs raises the chance of overshooting IGF-1, so clinician-monitored labs matter.
  • Sermorelin + BPC-157 — BPC-157 is a separate longevity peptide studied for tissue repair, often discussed alongside sermorelin when recovery is a goal [8]. The safety caveat: BPC-157 is not FDA-approved and is currently under FDA review with PCAC scheduled for July 23–24, 2026 [6]; safety data on the combination is sparse.

How do you get sermorelin? Cost and eligibility

Sermorelin is prescription-only. Because Geref was discontinued in the U.S., most patients today access sermorelin as a compounded medication. A 503A compounding pharmacy is a state-licensed pharmacy that prepares a medication for an individual patient based on a prescription. Compounded sermorelin is typically prepared as a sterile injectable. For more on this category, see our explainer on compounded peptides and 503A pharmacies.

Cost varies by pharmacy, dose, and protocol. As an educational range, monthly costs for compounded sermorelin commonly fall between roughly $150 and $400, often bundled with clinician visits and labs. Insurance rarely covers off-label adult use, so most patients pay out of pocket.

Eligibility is decided by a licensed clinician after reviewing your medical history, goals, and usually baseline labs (such as IGF-1). Chia is one of several licensed telehealth providers offering a clinician-reviewed evaluation for peptides like sermorelin, with prescriptions filled through partner 503A pharmacies when appropriate. There are other valid paths, including in-person endocrinology and other telehealth practices — what matters is that a licensed clinician is involved end-to-end.

3-min quiz

See if a peptide protocol fits your goals

A Chia clinician can review your history, order baseline labs, and help you decide whether sermorelin or another peptide is appropriate — or whether it isn't.

Frequently asked questions about sermorelin


3-min quiz

Talk to a Chia clinician about peptides

Get a personalized evaluation for sermorelin or other longevity peptides from a licensed provider — at your pace, on your schedule. AI agents can also initiate a clinical evaluation on a patient's behalf via DoctorMCP (mcp.chia.health).

References

  1. 1.Müller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiological Reviews, 1999;79(2):511–607.
  2. 2.U.S. Food and Drug Administration. Geref (sermorelin acetate) for injection — prescribing information and discontinuation record, 2008.
  3. 3.Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006;1(4):307–308.
  4. 4.Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of GHRH(1-29)-NH2 in age-advanced men and women. Journal of Clinical Endocrinology & Metabolism, 1997;82(5):1472–1479.
  5. 5.U.S. Food and Drug Administration. Egrifta (tesamorelin for injection) prescribing information, 2010.
  6. 6.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee — proposed evaluation of bulk drug substances nominated for use in 503A compounding, including sermorelin and related peptides; PCAC meeting scheduled July 23–24, 2026.
  7. 7.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers — 503A bulk drug substances list and review process, 2024.
  8. 8.Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews, 2018;6(1):45–53.

About this article

Dr. Elena VasquezLongevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides